Why High-Quality Raw Materials Are Vital | Producing Therapeutic Cardiomyocytes from iPSC Stem Cells

Albumin is a natural multitool; its binding properties, capacity to act as an antioxidant, ability to reduce surface adsorption and aggregation make it useful across multiple unit applications. The variability in serum-derived albumins directly results from albumin's innate binding properties. This variability can directly impact your process and product. Presented in excellent context through a case study of Heartseed’s innovative investigative therapy, join industry experts to discover how Recombumin® recombinant human albumin is supporting advanced therapies and lowering some of the barriers along the development journey.

Join Dr. Phil Morton, Albumedix’ Chief Technology Officer and Dr. Takehiko Kaneko, Head of R&D and Chief Medical Officer of Heartseed, to explore:

• The journey of Heartseed’s investigative cardiomyocyte therapy for heart failure patients, now in Phase I/II clinical trials
• The value albumin delivers across advanced therapy applications
• How implementing Recombumin® into a manufacturing process can help improve production and support stability
• The key benefits of using chemically defined raw materials
• And more…